Comparison of Giving Mecobalamin Supplements to Improve the Severity of Painful Diabetic Neuropathy
DOI:
https://doi.org/10.36590/jika.v6i3.874Keywords:
mecobalamin, diabetes mellitus, painfulAbstract
Diabetic Painful Neuropathy (DPN) is caused by the progressive loss of nerve fibers due to hyperglycemia, oxidative stress, andhomocysteinemia. Mecobalamin supplementation has shown potential in improving peripheral neuropathy symptoms by enhancing nerve conduction and alleviating neuropathic pain. However, its efficacy data remains limited. This research to investigated the effect of mecobalamin supplementation on the severity of Painful Diabetic Neuropathy in type 2 diabetes mellitus patients. This research is a non-randomized clinical trial, 16 patients were given 500 ?g of intramuscular Mecobalamin 8 times over 30 days (n=8) and 5 times over 10 days (n=8). Subjects underwent measurements VAS, TSS, BDNC and ENMG before and after intervention. VAS (p-value=0,022), TSS (p-value=0,020) and BDC (p-value=0,003) was significant improved in 8 times administration group. VAS (p-value=0,045) dan BDC (p-value=0,014) was significant improved in 5 times administration group, where TSS improved but not significant. The 8 times administration group was better compared to the 5 times administration group in improvement of VAS (p-value=0,016). Based on this research, The addition of mecobalamin 8 times and over 5 times in the management of Diabetic Neuropathic Pain can be useful in reducing neuropathic pain.
Downloads
References
Ahmed MA., Muntingh GL., Rheeder P. 2017. Perspectives on Peripheral Neuropathy as a Consequence of Metformin-Induced Vitamin B12 Deficiency in T2DM. International Journal of Endocrinology, 2017(1): 1-6. https://doi.org/10.1155/2017/2452853.
Cristian BA., Remus PA. 2018. Diabetic Neuropathy Prevalence and Its Associated Risk Factors in Two Representative Groups of Type 1 and Type 2 Diabetes Mellitus Patients from Bihor County. Maedica, 13(3): 229-334. https://doi.org/10.26574/maedica.2018.13.3.229
Callaghan BC., Cheng HT., Stables CL., Smith AL., Feldman EL. 2012. Diabetic Neuropathy: Clinical Manifestations and Current Treatments. The Lancet Neurology, 11(6): 521-534. https://doi.org/10.1016/S1474-4422(12)70065-0
Carrillo-Ibarra S., Miranda-Díaz AG., Sifuentes-Franco S., Cardona-Muñoz EG., Rodríguez-Carrizalez AD., Villegas-Rivera G., Román-Pintos LM. 2018. Effect of Statins on Oxidative DNA Damage in Diabetic Polyneuropathy. Journal of Circulating Biomarkers, 7(1): 1-7. https://doi.org/10.1177/1849454418804099
Corso CR., Martins DF., Borges SC., Beltrame OC., Telles JEQ., Buttow NC., Werner MF. 2018. Effect of Simvastatin on Sensorial, Motor, and Morphological Parameters in Sciatic Nerve Crush Induced-Neuropathic Pain in Rats. Inflammopharmacology, 26(3): 793-804. https://doi.org/10.1007/s10787-017-0425-1
Didangelos T., Doupis J., Veves A. 2014. Painful Diabetic Neuropathy: Clinical Aspects. Handbook of Clinical Neurology, 126: 53-61. https://doi.org/10.1016/B978-0-444-53480-4.00005-9
Didangelos T., Karlafti E., Kotzakioulafi E., Margariti E., Giannoulaki P., Batanis G., Tesfaye S., Kantartzis K. 2021. Vitamin B12 Supplementation in Diabetic Neuropathy: A 1-Year, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 13(2): 1-14. https://doi.org/10.3390/nu13020395
Dominguez JC., Ng AR., Damian LF. 2012. A Prospective, Open Label, 24-Week Trial of Methylcobalamin in The Treatment of Diabetic Polyneuropathy. Journal of Diabetes Mellitus, 2(4): 408-412. https://doi.org/10.4236/jdm.2012.24064
Hansen CS., Jensen JS., Ridderstråle M., Vistisen D., Jørgensen ME., Fleischer J. 2017. Vitamin B12 Deficiency is Associated with Cardiovascular Autonomic Neuropathy in Patients with Type 2 Diabetes. Journal of Diabetes and its Complications, 31(1): 202-208. https://doi.org/10.1016/j.jdiacomp.2016.08.025
Hébert HL., Veluchamy A., Torrance N., Smith BH. 2017. Risk Factors for Neuropathic pain in Diabetes Mellitus. The Journal of International Association The Study of Pain, 158(4): 560-568. https://doi.org/10.1097/j.pain.0000000000000785
Hernández-Ojeda J., Román-Pintos LM., Rodríguez-Carrízalez AD., Troyo-Sanromán R., Cardona-Muñoz EG., Alatorre-Carranza M del P., Miranda-Díaz AG. 2014. Effect of Rosuvastatin on Diabetic Polyneuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Study. Diabetes, Metabolic Syndrome and Obesity, 7: 401407. https://doi.org/10.2147/DMSO.S65500
Khalaf KM., Khudhair MS., Ashor AW. 2019. Vitamin B12 Status and Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus. The Journal of The Pakistan Medical Association, 3(8): 40-44. https://pubmed.ncbi.nlm.nih.gov/31603875/
Malik RA., Aldinc E., Chan SP., Deerochanawong C., Hwu CM., Rosales RL., Yeung CY., Fujii K., Parsons B. 2017. Perceptions of Painful Diabetic Peripheral Neuropathy in South-East Asia: Results from Patient and Physician Surveys. Advances in Therapy, 34(6): 1426-1437. https://doi.org/10.1007/s12325-017-0536-5.
Mizukami H., Ogasawara S., Yamagishi SI., Takahashi K., Yagihashi S. 2011. Methylcobalamin Effects on Diabetic Neuropathy and Nerve Protein Kinase C in Rats. European Journal of Clinical Investigation, 41(4): 442-450. https://doi.org/10.1111/j.1365-2362.2010.02430.x
Mørkrid K., Ali L., Hussain A. 2010. Risk Factors and Prevalence of Diabetic Peripheral Neuropathy: A Study of Type 2 Diabetic Outpatients in Bangladesh. International Journal of Diabetes in Developing Countries, 30(1): 11-17. https://pubmed.ncbi.nlm.nih.gov/20431800/
Narres M., Kvitkina T., Claessen H., Droste S., Schuster B., Morbach S., Rümenapf G., Van Acker K., Icks A. 2017. Incidence of Lower Extremity Amputations in The Diabetic Compared with The Non-Diabetic Population: A Systematic Review. Plos One, 12(8): 1-28. https://doi.org/10.1371/journal.pone.0182081
Newman C. 2019. Corrections to: Statin Safety and Associated Adverse Events: A Scientific Statement from The American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology, 39(5): 158. https://doi.org/10.1161/ATV.0000000000000081.
Pop-Busui R., Boulton AJM., Feldman EL., Bril V., Freeman R., Malik RA., Sosenko JM., Ziegler D. 2017. Diabetic Neuropathy: A position Statement by The American Diabetes Association. Diabetes Care, 40(1): 136-154. https://doi.org/10.2337/dc16-2042.
Pradeepa R., Rema M., Vignesh J., Deepa M., Deepa R., Mohan V. 2008. Prevalence and Risk Factors for Diabetic Neuropathy in an Urban South Indian Population: The Chennai Urban Rural Epidemiology Study (CURES-55). Diabetic Medicine, 25(4): 407-412. https://doi.org/10.1111/j.1464-5491.2008.02397.x.
Preston FG., Riley DR., Azmi S., Alam U. 2023. Painful Diabetic Peripheral Neuropathy: Practical Guidance and Challenges for Clinical Management. Diabetes, Metabolic Syndrome and Obesity. Dove Medical Press Ltd, 16: 1595-1612. https://doi.org/10.2147/DMSO.S370050
Rachmantoko R., Afif Z., Rahmawati D., Rakhmatiar R., Nandar SK. 2021. Diabetic Neuropathic Pain. Journal of Pain, Vertigo and Headache, 2(1): 8-12. https://doi.org/10.21776/ub.jphv.2021.002.01.3
Rahman T. 2017. Gambaran Kejadian Status Neuropati Perifer pada Penyandang Diabetes Mellitus di Puskesmas Sukoharjo. [Skripsi]. Universitas Muhammadyah Surakarta.
Schreiber AK., Nones CF., Reis RC., Chicorro JG. 2015. Diabetic Neuropathic Pain: Physiopathology and Treatment. World Journal of Diabetes, 6(3): 432-444. https://doi.org/10.4239/wjd.v6.i3.432.
Shillo P., Sloan G., Greig M., Hunt L., Selvarajah D., Elliott J., Gandhi R., Wilkinson ID., Tesfaye S. 2019. Painful and Painless Diabetic Neuropathies: What Is The Difference?. Current Diabetes Reports, 19(6): 1-13. https://doi.org/10.1007/s11892-019-1150-5.
Jensen TS. 2023. The pathogenesis of painful diabetic neuropathy and clinical presentation. Diabetes Research and Clinical Practice. Elsevier Ireland Ltd, 206: 1-5. https://doi.org/10.1016/j.diabres.2023.110753
Vieira G., Cavalli J., Gonçalves ECD., Gonçalves TR., Laurindo LR., Cola M., Dutra RC. 2017. Effects of Simvastatin Beyond Dyslipidemia: Exploring its Antinociceptive Action in An Animal Model of Complex Regional Pain Syndrome-Type 1. Frontiers in Pharmacology, 8: 1-13. https://doi.org/10.3389/fphar.2017.00584
Villegas-Rivera G., Román-Pintos LM., Cardona-Muñoz EG., Arias-Carvajal O., Rodríguez-Carrizalez AD., Troyo-Sanromán R., Pacheco-Moisés FP., Moreno-Ulloa A., Miranda-Díaz AG. 2015. Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Oxidative Medicine and Cellular Longevity, 2015(1): 1-15. https://doi.org/10.1155/2015/756294.
Yovera-Aldana M., Velasquez-Rimachi V., Huerta-Rosario A., More-Yupanqui MD., Osores-Flores M., Espinoza R., Gil-Olivares F., Quispe-Nolazco C., Quea-Velez F., Moran-Mariños C., Pinedo-Torres I., Alva-Diaz C., Pacheco-Barrios K. 2021. Prevalence and Incidence of Diabetic Peripheral Neuropathy in Latin America and the Caribbean: A systematic Review and Metaanalysis. Plos One, 16(5): 1-29. https://doi.org/10.1371/journal.pone.0251642.
Zhang M., Han W., Hu S., Xu H. 2013. Methylcobalamin: A Potential Vitamin of Pain Killer. Neural Plasticity, 2013(1): 1-6. https://doi.org/10.1155/2013/424651.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Andi Muhammad Irsyadat, Susi Aulina, Yudy Goysal, Andi Alfian Zainuddin, Mimi Lotisna, Muhammad Yunus Amran
This work is licensed under a Creative Commons Attribution 4.0 International License.
